Carleone Joseph 4
4 · SENSIENT TECHNOLOGIES CORP · Filed Apr 1, 2026
Research Summary
AI-generated summary of this filing
SENSIENT (SXT) Director Joseph Carleone Receives 422.547-Share Award
What Happened
- Joseph Carleone, a director of SENSIENT TECHNOLOGIES CORP (SXT), received an award of 422.547 shares (derivative) on 2026-03-31. The grant price is recorded as $0.00, so no cash was paid; the transaction is reported as an Award/Grant (code A).
- This award represents restricted/deferred stock issued under the issuer's director compensation arrangements (see footnotes). It is not an open-market purchase or sale and should be viewed as compensation rather than a market investment signal.
Key Details
- Transaction date: 2026-03-31; filing date: 2026-04-01 (timely).
- Security: 422.547 derivative shares granted at $0.00 (total value reported $0).
- Transaction code: A (award/grant).
- Post-transaction holdings: Not specified in the supplied filing summary.
- Relevant footnotes from the filing:
- F1: Includes restricted stock under the 2017 Stock Plan and shares in a dividend reinvestment plan.
- F2: Deferred stock converts to common stock on a one-for-one basis.
- F3: Grant reflects deferral of director fees under the Directors' Deferred Compensation Plan.
- F4: Shares of common stock will be issued upon termination of the reporting person's service as a director.
- Implication for investors: This is a routine director compensation grant (deferred/restricted stock), not a market purchase or sale. It increases potential future common shares once vested/issued per plan terms.
Insider Transaction Report
Form 4
Carleone Joseph
Director
Transactions
- Award
Deferred Stock
[F2][F3][F4]2026-03-31+422.547→ 23,780.4 total→ Common Stock (422.547 underlying)
Holdings
- 22,551.313
Common Stock
[F1]
Footnotes (4)
- [F1]Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
- [F2]Deferred stock converts to common stock on a one-for-one basis.
- [F3]Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
- [F4]Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone|2026-04-01